Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in MRK — Merck & Co., Inc.

CIK 1603466 STAMFORD, CT
Back to MRK Full portfolio

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$48,840,408
-$61,955,944 QoQ
Shares Held
380,081
-58.7% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#320
of 3,778 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Jun 30, 2026
CallValue
$13,158,400
CallShares
102,400
PutValue
$9,020,700
PutShares
70,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $681,590,231 across 11 Drug Manufacturers - General names. MRK ranks #5 (7.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GILD
Gilead Sciences, Inc.
 1,437,685 $181,637,122
2 GSK
GSK plc
 2,652,881 $139,064,022
3 AZN
Astrazeneca PLC
 711,547 $134,923,542
4 ABBV
AbbVie Inc.
 366,836 $92,310,611
5 MRK
Merck & Co., Inc.
This page 		380,081 $48,840,408
6 SNY
Sanofi
 820,078 $34,984,527
7 BIIB
Biogen Inc.
 88,149 $19,045,472
8 NVS
Novartis AG
 106,157 $16,636,925

All Filings in MRK

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,020,700 70,200
2026-06-30 $48,840,408 380,081
2026-06-30 $13,158,400 102,400
2026-03-31 $8,263,923 68,700
2026-03-31 $110,796,352 921,077
2026-03-31 $19,763,647 164,300
2025-12-31 $68,640,046 652,100
2025-12-31 $140,885,141 1,338,449
2025-12-31 $6,505,068 61,800
2025-09-30 $37,113,846 442,200
2025-09-30 $3,978,282 47,400
2025-09-30 $105,982,859 1,262,753
2025-06-30 $641,196 8,100
2025-06-30 $459,128 5,800
2025-06-30 $22,829,744 288,400
2025-03-31 $9,155,520 102,000
2025-03-31 $17,575,008 195,800
2024-12-31 $198,960 2,000
2024-12-31 $6,784,536 68,200
2024-09-30 $6,177,664 54,400
2024-09-30 $11,583,120 102,000
2024-06-30 $247,600 2,000
2024-06-30 $2,921,680 23,600
2024-03-31 $3,351,530 25,400
2024-03-31 $263,900 2,000
2023-12-31 $18,664,224 171,200
2023-12-31 $186,188,280 1,707,836
2023-12-31 $218,040 2,000
2023-09-30 $4,066,525 39,500
2023-09-30 $26,597,338 258,352
2023-09-30 $13,002,585 126,300
2023-06-30 $76,283,636 661,094
2023-03-31 $702,174 6,600
2023-03-31 $66,703,551 626,972
2022-12-31 $6,102,250 55,000
2022-12-31 $3,694,635 33,300
2022-12-31 $39,151,259 352,873
2022-09-30 $51,224,176 594,800
2022-06-30 $109,075,788 1,196,400
2022-03-31 $293,903,100 3,582,000
2022-03-31 $188,304,750 2,295,000
2021-12-31 $3,996,699 52,149
2021-09-30 $67,599,000 900,000
2021-09-30 $179,234,993 2,386,300
2021-06-30 $119,174,748 1,532,400
2021-06-30 $69,993,000 900,000
2021-03-31 $121,802,265 1,580,000
2021-03-31 $38,545,020 500,000
2020-12-31 $131,983,259 1,613,488
2020-09-30 $128,029,153 1,543,449

Report a Problem

Category
Description
Email (optional, for follow-up)